350 related articles for article (PubMed ID: 29875459)
1. CRISPR-based diagnostics.
Stower H
Nat Med; 2018 Jun; 24(6):702. PubMed ID: 29875459
[No Abstract] [Full Text] [Related]
2. [Advances in application of clustered regularly interspaced short palindromic repeats (CRISPR)/CRISPR-associated 9 system in stem cells research].
Sun SJ; Huo JH; Geng ZJ; Sun XY; Fu XB
Zhonghua Shao Shang Za Zhi; 2018 Apr; 34(4):253-256. PubMed ID: 29690746
[TBL] [Abstract][Full Text] [Related]
3. [Application of clustered regularly interspaced short palindromic repeats- associated protein 9 gene editing technology for treatment of HBV infection].
Wang YD; Liang QF; Li ZY; Zhao CY
Zhonghua Gan Zang Bing Za Zhi; 2018 Nov; 26(11):860-864. PubMed ID: 30616324
[TBL] [Abstract][Full Text] [Related]
4. Next-generation diagnostics with CRISPR.
Chertow DS
Science; 2018 Apr; 360(6387):381-382. PubMed ID: 29700254
[No Abstract] [Full Text] [Related]
5. Genome editing: CRISPR-Cas becoming more human.
Baumann K
Nat Rev Mol Cell Biol; 2017 Oct; 18(10):591. PubMed ID: 28811667
[No Abstract] [Full Text] [Related]
6. Genome editing: The efficient tool CRISPR-Cpf1.
Mahfouz MM
Nat Plants; 2017 Mar; 3():17028. PubMed ID: 28260792
[No Abstract] [Full Text] [Related]
7. In Vivo Delivery of CRISPR/Cas9 for Therapeutic Gene Editing: Progress and Challenges.
Mout R; Ray M; Lee YW; Scaletti F; Rotello VM
Bioconjug Chem; 2017 Apr; 28(4):880-884. PubMed ID: 28263568
[TBL] [Abstract][Full Text] [Related]
8. CRISPR-Cas in its prime.
Zlotorynski E
Nat Rev Mol Cell Biol; 2019 Dec; 20(12):718-719. PubMed ID: 31685954
[No Abstract] [Full Text] [Related]
9. Response to "Unexpected mutations after CRISPR-Cas9 editing in vivo".
Kim ST; Park J; Kim D; Kim K; Bae S; Schlesner M; Kim JS
Nat Methods; 2018 Apr; 15(4):239-240. PubMed ID: 29600990
[No Abstract] [Full Text] [Related]
10. Response to "Unexpected mutations after CRISPR-Cas9 editing in vivo".
Wilson CJ; Fennell T; Bothmer A; Maeder ML; Reyon D; Cotta-Ramusino C; Fernandez CA; Marco E; Barrera LA; Jayaram H; Albright CF; Cox GF; Church GM; Myer VE
Nat Methods; 2018 Apr; 15(4):236-237. PubMed ID: 29600989
[No Abstract] [Full Text] [Related]
11. Response to "Unexpected mutations after CRISPR-Cas9 editing in vivo".
Lescarbeau RM; Murray B; Barnes TM; Bermingham N
Nat Methods; 2018 Apr; 15(4):237. PubMed ID: 29600988
[No Abstract] [Full Text] [Related]
12. [CRISPR-Cas9 mediated genome editing in Caenorhabditis elegans].
Meng X; Zhou H; Xu S
Sheng Wu Gong Cheng Xue Bao; 2017 Oct; 33(10):1693-1699. PubMed ID: 29082717
[TBL] [Abstract][Full Text] [Related]
13. Inhibiting CRISPR.
Rusk N
Nat Methods; 2019 Mar; 16(3):218. PubMed ID: 30814697
[No Abstract] [Full Text] [Related]
14. Use of CRISPR/Cas Genome Editing Technology for Targeted Mutagenesis in Rice.
Xu R; Wei P; Yang J
Methods Mol Biol; 2017; 1498():33-40. PubMed ID: 27709567
[TBL] [Abstract][Full Text] [Related]
15. From CRISPR scissors to virus sensors.
Kocak DD; Gersbach CA
Nature; 2018 May; 557(7704):168-169. PubMed ID: 29730672
[No Abstract] [Full Text] [Related]
16. Expanding the Scope of CRISPR/Cpf1-Mediated Genome Editing in Rice.
Li S; Zhang X; Wang W; Guo X; Wu Z; Du W; Zhao Y; Xia L
Mol Plant; 2018 Jul; 11(7):995-998. PubMed ID: 29567453
[No Abstract] [Full Text] [Related]
17. Gene Editing for the Heart: Correcting Dystrophin Mutations.
McNally EM
Circ Res; 2017 Sep; 121(8):896-898. PubMed ID: 28963182
[TBL] [Abstract][Full Text] [Related]
18. Include egg donors in CRISPR gene-editing debate.
Niemiec E; Howard HC
Nature; 2019 Nov; 575(7781):51. PubMed ID: 31690864
[No Abstract] [Full Text] [Related]
19. CRISPR inhibitors.
Rusk N
Nat Methods; 2019 Jul; 16(7):577. PubMed ID: 31249419
[No Abstract] [Full Text] [Related]
20. CRISPR hacks enable pinpoint repairs to genome.
Dolgin E
Nature; 2017 Oct; 550(7677):439-440. PubMed ID: 29072279
[No Abstract] [Full Text] [Related]
[Next] [New Search]
